Quick preview
A useful Certificate of Analysis connects a named material and lot to defined tests, results and acceptance limits. This guide shows how to check identity, distinguish chromatographic purity from active content, compare documents and turn the review into a sample-release decision. Worked examples use hypothetical values; linked RAWESS products illustrate the questions to ask, not independent proof that a delivered lot conforms.
Requirements: what the COA must identify
Start with the material, not the percentage
Create an approval record for the exact offered grade: ingredient name, relevant identifiers, full composition, supplier or manufacturer reference, physical form and intended use. An INCI name helps describe cosmetic ingredients, but does not describe every carrier, preservative, counter-ion or concentration in a supplied preparation. Compare the label, specification and COA before interpreting any assay. A product called a peptide blend may contain several separately quantified components; approving the blend by one headline purity number can leave its actual composition unresolved.
Bind the result to the actual lot
Match the certificate lot number to the sample and, later, to the delivered packaging and delivery documents. Record the specification revision, analysis or release date, and relevant manufacture, expiry or retest information. A generic technical sheet or typical analysis is useful during shortlisting, but is not the analytical record of your shipment. If the evaluation sample and commercial batch differ, define what must be rechecked. Traceability should survive repacking and internal sample allocation, rather than end at the supplier's PDF filename.
Separate COA, SDS and TDS
The COA addresses stated batch results against a specification. The Safety Data Sheet addresses hazards and safe handling of the described material where applicable; the Technical Data Sheet gives grade-specific technical guidance. They are complementary, not competing certificates. A RAWESS product PDF is a catalog reference for selection, not any of these controlled lot-release records. Use the COA, SDS and TDS comparison to set a document request. A complete-looking folder can still contain mismatched grades or obsolete revisions, so review consistency as well as presence.
Define the decision the evidence supports
For an EU cosmetic safety assessment, Annex I to Regulation 1223/2009 calls for information including composition, physical and chemical characteristics and stability, microbiological quality, and impurities, traces and packaging information. It does not prescribe one universal COA panel for every ingredient or make a supplier certificate a finished-product safety report. Translate your material and formulation risks into acceptance criteria with the relevant quality and safety reviewers. Keep raw-material approval separate from the decision to place the complete cosmetic on the market. [1]
Selection criteria: how to interpret the analytical numbers
Read the method and reporting basis together
For each reported property, ask what is measured, by which method, in which units and on which basis. “HPLC” names a technique, not a complete quantitative method. Chromatographic area purity may describe the relative detector response of separated peaks, whereas active mass content requires a suitable quantitative determination. Water, counter-ions, carriers and detector response can change the relationship. Ask how identity was established and how the assay was calibrated. A method reference is a starting point for review, not proof that different laboratories will obtain interchangeable results.
Work a dry-basis example without turning it into a claim
Suppose a hypothetical ingredient has 99.0% assay on a dry basis and 2.0% water. If, and only if, the documented basis allows water to be the sole correction, the estimated as-supplied mass fraction is 0.990 × (1 − 0.020) = 0.9702, or 97.02%. One gram would then contain about 970.2 mg on that defined assay basis. Do not apply this calculation to an HPLC area percentage, an unspecified loss-on-drying result or a composition containing additional unaccounted components. These invented teaching inputs are not RAWESS lot results or a recommended cosmetic dose.
Compare the right property for each product
For Niacinamide USP, ask how the assay basis and residual nicotinic acid are specified; a headline assay does not answer both questions. For Green Tea EGCG, distinguish EGCG from total catechins or total polyphenols. For Copper Peptide GHK-Cu, separate identity of the complex, chromatographic purity and documented active mass content. For Xanthan Gum Clear, viscosity needs conditions such as concentration, temperature and measurement procedure. The linked catalog pages establish the offered material and review topics; request current methods and batch evidence before acceptance.
Review limits and missing tests without guessing
Distinguish a numerical result, a less-than result, “not detected” and “conforms.” “Not detected” only has meaning in relation to the method and its detection capability; it is not an unrestricted statement of absence. Decide whether an omitted test is unnecessary, controlled through another justified route, or an unresolved gap. Commission guidance on cosmetic safety reports explains the role of raw-material information, impurities and stability in the safety assessment. Choose risk-relevant tests rather than copying every possible panel onto every ingredient. [2]
Typical catalog information vs batch evidence
| Document or observation | Useful for | Does not establish |
|---|---|---|
| Product guide / typical value | Shortlisting identity and questions | Results of the delivered lot |
| Lot COA with defined methods | Reviewing stated batch conformity | Universal formulation compatibility |
| Controlled formulation trial | Checking the intended system | Identity or safety without supporting review |
Practical recommendation: move from document review to release
Investigate inconsistencies, not typography
Neither many decimal places, a short certificate, a round result nor a decorative stamp proves accuracy or fraud. If results are unexpectedly identical across lots, ask about rounding, reporting conventions, specification-only fields and the underlying testing practice. If methods or units change, compare the impact before comparing trends. Request clarification or appropriate supporting records and record the answer. When justified, agree independent testing on an identified sample with a competent laboratory. A confirmatory result is most useful when sampling, method and acceptance limit were defined before the sample was sent.
Run a representative sample evaluation
Use an agreed sampling plan and handling conditions to obtain a representative evaluation sample. Record the lot, container condition, opening date and storage history. Follow the SDS and current technical instructions; avoid contaminating the sample while investigating it. Test the intended incorporation route in a controlled formula and compare with a reference or control where relevant. A material may meet its incoming specification yet fail your formula's clarity, viscosity, odor or stability requirement. Conversely, a visually attractive prototype does not resolve an uncertain ingredient identity or analytical basis.
Use explicit hold, accept and change decisions
Create a short review record with each required check, evidence location, result, reviewer and open question. Hold the material when identity, batch traceability or a critical acceptance criterion is unresolved. Accept it only for the defined specification and use after the necessary review, rather than treating one certificate as blanket approval for future batches. Record deviations and their disposition. Reassess when composition, source, method, specification, packaging or process changes; the scope of reassessment should follow the significance of the change, not merely a supplier's new product name.
Keep a usable evidence trail
Retain the approved specification, actual lot COA, applicable SDS, TDS revision, sample records and release decision together. Assign responsibility for retrieving updates and resolving discrepancies. If a later complaint arises, this file should show which material was used and why it was accepted. For purchasing, state the required grade, formula format, destination market, quantity and acceptance tests in the sample and quotation brief. Download the English product guides as planning aids, then request the controlled documents for the order under review.
Peptide COA: what the certificate can and cannot show
Peptides add a step that a small molecule does not: the substance has to be the right sequence, and the number reported as purity is rarely the number you weigh on the balance. A certificate that reports one HPLC percentage leaves both questions open.
Identity is a different test from purity
An HPLC area percentage describes how much of the UV-absorbing material elutes as the main peak under the stated method. It does not establish the sequence. Ask which identity method accompanies it: LC-MS or MALDI-TOF mass against the theoretical mass, amino-acid analysis, or peptide mapping. For a copper complex such as GHK-Cu, copper content is a further identity input; a peptide content result that ignores the complexed metal does not describe the same material.
Three bases are routinely confused
| Basis | What the number counts | What it misses |
|---|---|---|
| Chromatographic purity (HPLC area %) | Share of detected peak area assigned to the main peak | Water, counter-ion and non-UV-absorbing impurities |
| Assay as supplied | Content in the material as delivered, including its water and salt | Whether the salt is the one your calculation assumes |
| Net peptide content | Mass of the peptide itself after water and counter-ion are removed | Requires a separate determination, not a restatement of purity |
As an illustrative arithmetic exercise, not a specification: a 1 kg lot reported at 95.0% chromatographic purity and 6.0% water, supplied as the acetate salt with acetate accounting for about 8% of the dry mass, works out to roughly 820 g of peptide. Pricing per kilogram of raw material and pricing per gram of peptide are therefore different quotations even when the labels look identical. Replace the percentages in this paragraph with your own lot data before using the result.
Line items to require on a peptide COA
- Lot number that matches the shipping documents and the retained sample.
- Identity: mass result against theoretical, plus amino-acid analysis or mapping where available.
- Purity with the method, column, wavelength and gradient stated, not only the result.
- Water content by Karl Fischer, and the counter-ion with its determination method.
- Net peptide content, or the calculation connecting assay, water and salt.
- Heavy metals, microbial limits and appearance for the grade supplied.
- Storage and shipping conditions under which the result was obtained.
Read those figures against the grade actually quoted: Copper Peptide GHK-Cu, argireline and Matrixyl 3000 do not share a specification, a counter-ion or a storage condition. The arithmetic is set out in calculating cosmetic peptide active concentration, and the family overview is on the cosmetic peptides page.
Summary and next step
Approve a defined material against a defined specification, then verify its behavior in your formula. The most useful COA is the one whose identity, method, basis and lot can be traced into a documented decision.
References and data summary
The sources below support different levels of evidence. The calculations are explained separately so no illustrative number is mistaken for a measured batch result.
Read and checked: 1 November 2026
[1] Regulation (EC) 1223/2009 — Article 10 and Annex I. Source version / publication: 2026-05-18.
Article 10 and Annex I: framework and information for the cosmetic safety assessment. Legal text supports the required assessment categories, not a universal incoming test panel or approval of a RAWESS ingredient.
[2] Commission Implementing Decision 2013/674/EU — Guidelines on Annex I. Source version / publication: 2013-11-25.
Annex guidance: composition, raw-material information, stability, microbiological quality and impurities. Guidance helps interpret the safety-report information; tests and acceptance criteria remain material- and use-specific.
Data and calculation notes
Illustrative arithmetic only: 99.0% dry-basis assay and 2.0% water give 97.02% as supplied under the stated single-correction assumption. None of these values is a reported lot result. Product links support catalog identity and the listed review topics; the RAWESS PDF is not a batch COA.
Product evidence used in this article
- Niacinamide USP — Catalog reference; request current lot documents.
- Green Tea EGCG — Catalog reference; request current lot documents.
- Copper Peptide GHK-Cu — Catalog reference; request current lot documents.
- Xanthan Gum Clear — Catalog reference; request current lot documents.
Peptide COA and the surrounding families
The verification steps above apply unchanged to peptide lots: identity by mass spectrometry, purity by chromatography, and the active mass basis stated on the certificate. Compare the peptide family in cosmetic peptides, the assay and grade comparison in cosmetic active ingredients, and a water-soluble worked example in Niacinamide USP. For the catalogue side of the same question, see the Copper Peptide GHK-Cu specification.